ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,855Medicare Part D Prescriptions Filled, Including Refills

Rank: 690 out of 5176

$520K Total Retail Price of All Prescriptions

Rank: 1086 out of 5176

422 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 589 483 1 13
SIMVASTATIN 373 349 2 1
METOPROLOL TARTRATE 330 295 3 6
MIRTAZAPINE 320 313 4 45
LISINOPRIL 316 274 5 5
AMLODIPINE BESYLATE 306 245 6 2
METFORMIN HCL 224 212 7 7
FUROSEMIDE 219 207 8 8
OMEPRAZOLE 216 173 9 3
ENALAPRIL MALEATE 199 180 10 22
LEVETIRACETAM 183 162 11 92
LEVOTHYROXINE SODIUM 167 120 12 4
HYDROCHLOROTHIAZIDE 143 109 13 10
ALENDRONATE SODIUM 142 125 14 18
RISPERIDONE 137 89 15 78
TAMSULOSIN HCL 134 123 16 20
GABAPENTIN 117 90 17 21
DONEPEZIL HCL 116 104 18 28
RANITIDINE HCL 112 112 19 36
ALBUTEROL SULFATE 101 93 20 99
TRIHEXYPHENIDYL HCL 95 53 R 21 370
LOSARTAN POTASSIUM 94 90 22 14
HALOPERIDOL LACTATE 93 68 23 386
LANTUS 92 86 24 66
METOPROLOL SUCCINATE 89 85 25 11
SPIRIVA 85 80 26 54
HALOPERIDOL 83 70 27 145
LATANOPROST 82 81 28 185
DIVALPROEX SODIUM 80 22 29 104
VALPROIC ACID 77 65 30 195
TRAZODONE HCL 76 75 31 71
CLOPIDOGREL 75 71 32 26
NIFEDIPINE ER 72 71 33 48
NEXIUM 71 51 34 16
QUETIAPINE FUMARATE 69 57 35 75
CARBIDOPA-LEVODOPA 67 67 36 98
BENZTROPINE MESYLATE 64 51 R 37 201
ZOLPIDEM TARTRATE 63 30 38 17
NAPROXEN 61 42 39 95
SINGULAIR 60 53 40 62
COMBIGAN 60 60 40 584
OXYCODONE-ACETAMINOPHEN 60 39 S2 40 101
AZITHROMYCIN 56 45 43 42
ATENOLOL 55 55 44 12
BRIMONIDINE TARTRATE 53 53 45 244
CITALOPRAM HBR 52 41 46 31
MONTELUKAST SODIUM 51 37 47 123
VENTOLIN HFA 50 42 48 64
AMOX TR-POTASSIUM CLAVULANATE 50 31 48 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.